AUROBINDO PHARMA
Back to Balance Sheet
|
AUROBINDO PHARMA Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Deferred Tax Assets / Liabilities | ₹-990 Cr | ₹-856 Cr | ₹-288 Cr | ₹122 Cr | ₹122 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of AUROBINDO PHARMA ?
Year | Deferred Tax Assets / Liabilities |
---|---|
Mar2025 | ₹-990 Cr |
Mar2024 | ₹-856 Cr |
Mar2023 | ₹-288 Cr |
Mar2022 | ₹122 Cr |
Mar2021 | ₹122 Cr |
How is Deferred Tax Assets / Liabilities of AUROBINDO PHARMA Trending?
Years | Deferred Tax Assets / Liabilities | % Change | |
---|---|---|---|
Mar2025 | ₹-990 Cr | Negative | |
Mar2024 | ₹-856 Cr | Negative | |
Mar2023 | ₹-288 Cr | Negative | |
Mar2022 | ₹122 Cr | 0.40 | |
Mar2021 | ₹122 Cr | - |
Compare Deferred Tax Assets / Liabilities of peers of AUROBINDO PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
AUROBINDO PHARMA | ₹62,894.8 Cr | 4% | -6.1% | -28.4% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹394,115.0 Cr | 3.5% | -3.4% | -5.8% | Stock Analytics | |
DIVIS LABORATORIES | ₹162,735.0 Cr | 3.7% | -10.2% | 25.6% | Stock Analytics | |
CIPLA | ₹126,313.0 Cr | 5.3% | 6.1% | -1.3% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹122,592.0 Cr | 1.4% | 4.6% | 7.6% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹105,095.0 Cr | 3.9% | 0% | -9.9% | Stock Analytics |
AUROBINDO PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
AUROBINDO PHARMA | 4% |
-6.1% |
-28.4% |
SENSEX | -0% |
-2.4% |
1.2% |
You may also like the below Video Courses